“Dr. helped my boyfriend so much. On vacation he got an eye infection and Dr. made sure he got what he needed even though they were slammed. Very nice guy.”
Eye Injections and Heart Risk: What Patients Should Know
How the Injection Is Given
Most patients are surprised by how quick and manageable the injection visit actually is. Knowing what to expect beforehand takes a great deal of the anxiety out of it.
Before the injection, your eye is numbed with drops or gel so discomfort is minimal. The eye and eyelids are then cleaned with a solution called povidone-iodine, which kills surface bacteria and is the single most important step for preventing infection. A small clip called an eyelid speculum holds the lids gently open while the injection is given.
Most people feel pressure or a brief pinch rather than sharp pain. The entire procedure typically takes only a few minutes, and you are usually free to go home shortly afterward.
The hardest part for many patients is not a single injection but the ongoing series. In chronic conditions like wet AMD, diabetic macular edema, and retinal vein occlusion, injections often need to be repeated. Early in treatment, follow-up visits are usually about four to six weeks apart. Over time, many patients move to longer intervals as the retina stabilizes.
If the frequency feels burdensome, say so. The schedule can sometimes be adjusted, and your Retina Specialist will work with you to find an approach that protects your vision while being realistic about your life.
A small amount of anti-VEGF medicine can pass from the eye into the bloodstream after an injection. This is the reason researchers began studying whether these drugs affect the heart and blood vessels. Because the same drug family is used in much larger doses intravenously for cancer treatment, scientists had a direct way to test the concern.
The sections that follow explain what those studies actually found in plain terms.
What the Research Shows About Heart Risk
This is the question that brings most patients to this page, and the honest answer is more reassuring than many people expect. Large, well-designed studies have specifically examined cardiovascular risk from these injections.
A major review that combined 74 randomized clinical trials involving more than 23,000 patients found that anti-VEGF eye injections did not increase the risk of heart attack, stroke, or cardiovascular death compared with control groups. A separate analysis of 13 randomized trials also concluded that intravitreal anti-VEGF therapy is not linked to a higher risk of clot-related events such as stroke and heart attack.
These are large, rigorous studies, not small observations. The consistency across them provides real reassurance, even though no population study can make a personal promise.
Timing matters more than most people realize. Research has found that patients who experienced a heart attack or ischemic stroke within the six months before an injection had a meaningfully higher risk of another such event afterward, compared with patients who had no recent history. That is a specific and important exception to the otherwise reassuring overall picture.
This does not mean treatment must stop permanently. It means that in the weeks and months right after a serious cardiac or stroke event, your Retina Specialist and your cardiologist or neurologist should coordinate before proceeding. Let both teams know about the recent event so they can decide together on the safest timing.
Every medical decision is really a comparison, and stopping treatment is never a risk-free choice. Wet AMD and diabetic macular edema will continue damaging the macula without treatment. The abnormal vessels these drugs target do not pause on their own. Left untreated, progressive central vision loss is a real and likely outcome.
So the question is not risk versus no risk. It is a small, well-studied cardiovascular consideration on one side, and a significant risk of losing the central vision you need for daily life on the other. That is exactly the kind of balance your Retina Specialist is trained to help you navigate.
Side Effects: From the Eye to the Whole Body
Like all medical treatments, anti-VEGF injections carry a range of possible side effects. Most are minor and short-lived, but a few are serious enough to require prompt attention.
Most side effects after an injection are local, mild, and temporary. A small red patch on the white of the eye, called a subconjunctival hemorrhage, can appear where the needle entered and typically clears within about a week. You may also notice mild irritation, watering, or grittiness for a day or two, and some patients notice a few new floaters immediately after the injection.
These are expected and generally fade without treatment. They are very different from the warning signs described next, which require same-day attention.
Certain complications are uncommon but important to recognize early. Endophthalmitis, which is a serious infection inside the eye, is rare after intravitreal injections, with reported rates of roughly two to eight cases per ten thousand injections. Other rare risks include a significant rise in eye pressure, retinal detachment, and bleeding inside the eye.
The reason these matter is that catching them early dramatically improves the outcome. Increasing pain, growing redness, or a drop in vision in the days after an injection should be treated as an emergency, not a wait-and-see situation.
As noted above, a small amount of drug can enter the bloodstream from the eye. Despite this, pooled trial evidence has not shown a higher rate of major cardiovascular events with anti-VEGF injections compared with control groups in large study populations. The diabetic retinopathy subset of one large review did show a higher mortality signal that researchers continue to evaluate, which is one reason your full health history belongs in every conversation with your Retina Specialist.
Because these are group averages and not individual predictions, your own diagnosis, heart history, and the recency of any cardiac event all factor into the picture.
Who Should Pause and Talk to a Specialist First
Most patients can continue injections safely, but a few situations call for a careful conversation before the next scheduled dose. Knowing when to pause is just as important as knowing when to proceed.
There are specific circumstances where an injection should be held until conditions improve. An active infection in or around the eye, active inflammation inside the eye, or a known allergy to the drug being used are all reasons to delay. Proceeding in any of these situations increases the risk of serious complications.
A delay is not a cancellation. Once the eye is calm, treatment can resume safely, and your Retina Specialist will work with you on rescheduling.
A very recent stroke or heart attack is the situation where extra care is most clearly warranted. Research has identified a meaningful increase in risk when injections are given within six months of either event, and clinical guidance advises caution in patients with recent cardiac or cerebrovascular events, or those with known coronary artery disease.
If you have had a stroke or heart attack recently, do not simply skip your appointment without calling first. Contact your Retina Specialist and your cardiologist or neurologist together, and let them coordinate the timing. The goal is to protect both your heart and your sight, and that works best when both specialists are in the loop.
Anti-VEGF drugs block a signal that a developing pregnancy also uses, so extra care is warranted for anyone who is pregnant or planning to become pregnant. The prescribing information for some of these drugs recommends that women who can become pregnant use effective birth control before, during, and for at least three months after the final injection.
If you are pregnant, trying to conceive, or breastfeeding, tell your Retina Specialist before your next injection. The plan can be adjusted, and the decision should involve both your eye doctor and your obstetric care team.
Warning Signs and When to Seek Care
Most patients do very well after injections, but knowing which symptoms need urgent attention could protect your vision. A quick response to the right warning signs makes a real difference.
Some symptoms after an injection should never be ignored until the next scheduled visit. Contact your Retina Specialist the same day, or seek urgent eye care, if you notice any of the following in the days after your injection.
- New or increasing pain in the eye
- Redness that is growing rather than settling
- Blurred, decreased, or suddenly changed vision
- Increasing sensitivity to light
These can be early signs of infection inside the eye, and getting evaluated quickly gives the best chance of protecting your sight. When in doubt, call rather than wait.
Because this page addresses heart and brain safety, it is worth knowing the signs of a stroke as well. Stroke symptoms come on suddenly and may include numbness or weakness on one side of the face, arm, or leg, sudden confusion or difficulty speaking, sudden trouble seeing in one or both eyes, sudden trouble walking or loss of balance, or a sudden severe headache with no clear cause.
The FAST check is a simple tool to remember: Face drooping, Arm weakness, Speech difficulty, Time to call 911. A stroke is a medical emergency at any time, regardless of your injection schedule. Call 911 immediately if you or someone nearby experiences these symptoms.
Not every concern is an emergency, and knowing where to direct routine questions saves unnecessary worry. For eye-related questions such as new floaters, mild discomfort, or changes in vision that develop after the first day, your Retina Specialist's office is the right first call. For heart-related concerns or blood pressure changes, your primary care doctor or cardiologist should be kept in the loop, particularly after any recent cardiac event.
Keeping both care teams informed allows them to coordinate injection timing around your overall health, which is the safest approach for anyone managing both eye and heart conditions.
Frequently Asked Questions
These questions address specific decisions and situations that patients often face but that are not fully covered by the explanations above.
In most cases, yes. Blood thinners and aspirin are generally continued during anti-VEGF treatment because stopping them can carry its own serious heart and stroke risks that often outweigh any eye-related concern. You may be more likely to develop a small red bruise on the white of the eye after the injection, but that is a cosmetic nuisance, not a danger to vision or to the eye itself. Never stop a blood thinner or heart medicine on your own. Always consult the doctor who prescribed it before making any change, and make sure both your prescribing doctor and your Retina Specialist know about each other.
This is a reasonable concern given that anti-VEGF drugs act on blood vessels. In large pooled trials, the overall cardiovascular picture has been reassuring, without a demonstrated increase in major events. However, if you already have high blood pressure, it is important to continue taking your prescribed medications and keep up with regular monitoring. Let your Retina Specialist and your primary care doctor know about any significant changes in your readings so both teams can track the trend and stay coordinated.
For most patients, the heart safety profiles of the available anti-VEGF drugs are broadly similar, and drug choice is usually driven by your diagnosis, how your retina responds, and how often you need treatment. If you have significant heart disease or a recent cardiac history, bring that up directly with your Retina Specialist. In some cases the choice of drug or the injection interval can be tailored with your cardiac history in mind, and having that conversation ensures your treatment plan reflects your full health picture.
Stopping treatment is not a neutral decision. In wet AMD and diabetic macular edema, the abnormal vessels that anti-VEGF drugs control will continue leaking and growing without treatment, and central vision loss can progress quietly and quickly. If fear is behind the thought of stopping, bring that conversation to your Retina Specialist before making any decision. Your Retina Specialist can walk through your actual heart risk alongside your actual eye risk so that any choice you make is based on real information rather than anxiety alone.
If you have had a heart attack, stroke, or been diagnosed with coronary artery disease recently, coordinating with a cardiologist before continuing injections is a reasonable and often advisable step. For patients who have stable heart disease managed with regular medication and no recent events, a conversation with your primary care doctor is often sufficient. Either way, make sure all of your treating physicians know you are receiving intravitreal injections. Good communication between your care teams removes a great deal of uncertainty and helps everyone make the safest decisions for you.
Your Retina Specialist reviews your retinal imaging and vision at each visit to determine whether your disease is stable enough to extend the interval between injections. This approach, sometimes called treat-and-extend, is commonly used and can meaningfully reduce the total number of visits without sacrificing the protection of your vision. If the current frequency feels like a burden, mention it at your next visit. A longer interval may already be appropriate for where your disease is, and your care team can only evaluate that if you raise the question.
Schedule a Visit With Our Team
Our team at Atlantic Retina Center brings fellowship-trained, board-certified expertise exclusively to the retina, vitreous, and macula, serving patients throughout the Eastern Shore of Maryland and central and southern Delaware. If you have questions about anti-VEGF injections, concerns about your heart history, or simply want a clearer picture of your treatment plan, we are here to help. We take the time to understand your full health history so that every decision we make together is the right one for you.